[1]
F. Bastos Goncalves and H. D. Valentim, “LIFES AND LIMBS: ACCESS TO SECONDARY PREVENTION WITH AAS AND RIVAROXABAN IN PATIENTS WITH SYMPTOMATIC PERIPHERAL ARTERIAL DISEASE”, Angiol Cir Vasc, vol. 16, no. 4, pp. 197–199, Mar. 2021.